GGrantIndex
Sort

34,240 grants matching atherosclerosis

Linking Spatial Variations Shear Stress-Oxidative Stress

$400,138
Tzung K Hsiai · University Of Southern California · R01 · FY2006 · HL

Anti-inflammatory Cytokines in Atherosclerosis

$400,121
William A Boisvert · Brigham And Women'S Hospital · R01 · FY2006 · HL

Signal Transduction by Oxysterols

$400,063
Rajat Rohatgi · Stanford University · R01 · FY2017 · GM

Post-DPP Follow-up Study

$400,039
Christopher D. Saudek · Johns Hopkins University · U01 · FY2006 · DK

Role of CITED2 in cardiovascular disease

$400,000
Ganapati Holanagadde Mahabaleshwar · Case Western Reserve University · R01 · FY2018 · HL

Mechanisms and Consequences of Stress-Induced Macrophage Death in Atherosclerosis

$400,000
Ira A Tabas · Columbia University Health Sciences · R01 · FY2017 · HL

HDL, platelet progenitors, atherosclerosis and thrombosis

$400,000
Nan Wang · Columbia University Health Sciences · R01 · FY2018 · HL

HDL, platelet progenitors, atherosclerosis and thrombosis

$400,000
Nan Wang · Columbia University Health Sciences · R01 · FY2014 · HL

HDL Proteomics for Heart Disease Detection

$400,000
Bryan Prazen · Insilicos · R44 · FY2010 · HL

Hepatic PLTP as a target for lowering LDL-c

$400,000
Weijun Jin · Suny Downstate Medical Center · R56 · FY2014 · HL

Mechanisms and Consequences of Stress-Induced Macrophage Death in Atherosclerosis

$400,000
Ira A Tabas · Columbia University Health Sciences · R01 · FY2016 · HL

p90RSK-ERK5 module, efferocytosis, and vulnerable plaque formation

$400,000
Jun-Ichi Abe · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · HL

HDL, platelet progenitors, atherosclerosis and thrombosis

$400,000
Nan Wang · Columbia University Health Sciences · R01 · FY2017 · HL

Interrogation of novel pathways regulating VLDL production and plasma lipids

$400,000
Daniel James Rader · University Of Pennsylvania · R01 · FY2012 · HL

Vascular Endothelial Activation in Sleep Apnea

$400,000
Sanja Jelic · Columbia University Health Sciences · R01 · FY2012 · HL

Role of CITED2 in cardiovascular disease

$400,000
Ganapati Holanagadde Mahabaleshwar · Case Western Reserve University · R01 · FY2019 · HL

TTC39B in Metabolism

$400,000
Alan Richard Tall · Columbia University Health Sciences · R01 · FY2018 · HL

Biodegradable polymetal nanoparticle CT contrast agents for vascular imaging

$400,000
David Peter Cormode · University Of Pennsylvania · R01 · FY2017 · HL

p90RSK-ERK5 module, efferocytosis, and vulnerable plaque formation

$400,000
Jun-Ichi Abe · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · HL

Novel mechanisms and 'complement-ary' therapy in periodontitis

$400,000
Georgios Hajishengallis · University Of Pennsylvania · R01 · FY2012 · DE

Next-Generation Cardiovascular Risk Assessments Via State-Of-The-Art Lipoprotein Characterization

$400,000
Sean German · Electronic Biosciences, Inc. · R43 · FY2024 · HL

Mechanisms of Defective Efferocytosis in Atherosclerosis

$400,000
Ira A Tabas · Columbia University Health Sciences · R01 · FY2012 · HL

Insulin action, reverse cholesterol transport, and HDL function

$400,000
Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2019 · HL

HDL Proteomics for Heart Disease Detection

$400,000
Bryan Prazen · Insilicos · R44 · FY2012 · HL

Targeting NF-kB in Atherosclerosis

$400,000
Michael J May · University Of Pennsylvania · R01 · FY2012 · HL